✦ LIBER ✦

A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients

✍ Scribed by Nemunaitis, J; Senzer, N; Sarmiento, S; Zhang, Y-A; Arzaga, R; Sands, B; Maples, P; Tong, A W

Book ID: 110019478
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 185 KB
Volume: 14
Category: Article
ISSN: 0929-1903
DOI: 10.1038/sj.cgt.7701080

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous infusion of a replication-se

Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

✍ Nemunaitis, J; Cunningham, C; Buchanan, A; Blackburn, A; Edelman, G; Maples, P; 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 671 KB

A phase I trial of dactinomycin intraven

A phase I trial of dactinomycin intravenous infusion in patients with advanced malignancies

✍ Martin S. Blumenreich; Thomas M. Woodcock; Stephen P. Richman; Mariesa K. Jones; 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 3 views

Eighteen patients with advanced malignancies refractory to other forms of treatment were given dactinomycin (Act D) as continuous intravenous infusions. Their median age was 51 years (range, 36-67); their median performance status was 50 (range, 40-90) on the Karnofsky scale. Act D was administered

Pilot trial of intravenous infusion of a

Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients

✍ Nemunaitis, J; Cunningham, C; Tong, A W; Post, L; Netto, G; Paulson, A S; Rich, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 201 KB

A phase I study of intermittent infusion

A phase I study of intermittent infusion cladribine in patients with solid tumors

✍ Ken Kobayashi; Nicholas J. Vogelzang; Sheila M. O'Brien; Richard L. Schilsky; Ev 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

Phase-I trial of intravenous continuous

Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomas

✍ Bertram Wiedenmann; Peter Reichardt; Ulrich Räth; Lorenz Theilmann; Birgit Schül 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 410 KB

209 Phase I clinical trial in patients w

209 Phase I clinical trial in patients with refractory solid tumors: the weekly 24 hour intravenous infusion of aviscumine, a recombinant ribosome-inactivating protein

✍ P. Schöffski; I. Breidenbach; O. Bolte; M. Stadler; S. Zilz; K. Wilhelm-Ogunbiyi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 294 KB